BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 27577706)

  • 1. Regulation of hypoxia-inducible factor-1α, regulated in development and DNA damage response-1 and mammalian target of rapamycin in human placental BeWo cells under hypoxia.
    Zhou F; Guan LB; Yu P; Wang XD; Hu YY
    Placenta; 2016 Sep; 45():24-31. PubMed ID: 27577706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-induced regulation of placental REDD1 and mTOR was impaired in a rat model of estrogen-induced cholestasis.
    Zhou F; Chen H; Wang X; Yu P; Hu Y
    Arch Gynecol Obstet; 2016 Nov; 294(6):1219-1226. PubMed ID: 27549090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
    Liu NN; Zhao N; Cai N
    IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of hypoxia-regulated genes and glycometabolic genes in placenta from patients with intrahepatic cholestasis of pregnancy.
    Wei W; Hu YY
    Placenta; 2014 Sep; 35(9):732-6. PubMed ID: 25063250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of REDD1-mediated mammalian target of rapamycin pathway and hypoxia-inducible factor-1α regulation in human breast cancer.
    Koo JS; Jung W
    Pathobiology; 2010; 77(6):289-300. PubMed ID: 21266827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic condition- and high cell density-induced expression of Redd1 is regulated by activation of hypoxia-inducible factor-1alpha and Sp1 through the phosphatidylinositol 3-kinase/Akt signaling pathway.
    Jin HO; An S; Lee HC; Woo SH; Seo SK; Choe TB; Yoo DH; Lee SB; Um HD; Lee SJ; Park MJ; Kim JI; Hong SI; Rhee CH; Park IC
    Cell Signal; 2007 Jul; 19(7):1393-403. PubMed ID: 17307335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of extracellular signal-regulated kinase and AKT cascades in regulating hypoxia-induced angiogenic factors produced by a trophoblast-derived cell line.
    Fujita D; Tanabe A; Sekijima T; Soen H; Narahara K; Yamashita Y; Terai Y; Kamegai H; Ohmichi M
    J Endocrinol; 2010 Jul; 206(1):131-40. PubMed ID: 20371567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Canales J; Valenzuela M; Bravo J; Cerda-Opazo P; Jorquera C; Toledo H; Bravo D; Quest AF
    Front Cell Infect Microbiol; 2017; 7():92. PubMed ID: 28401064
    [No Abstract]   [Full Text] [Related]  

  • 11. Inflammatory stimulation and hypoxia cooperatively activate HIF-1{alpha} in bronchial epithelial cells: involvement of PI3K and NF-{kappa}B.
    Jiang H; Zhu YS; Xu H; Sun Y; Li QF
    Am J Physiol Lung Cell Mol Physiol; 2010 May; 298(5):L660-9. PubMed ID: 20139176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells.
    Sudhagar S; Sathya S; Lakshmi BS
    Br J Cancer; 2011 Sep; 105(7):953-60. PubMed ID: 21897387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced regulation of mTOR signaling by miR-7 targeting REDD1.
    Seong M; Lee J; Kang H
    J Cell Biochem; 2019 Mar; 120(3):4523-4532. PubMed ID: 30302791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway.
    Pore N; Jiang Z; Shu HK; Bernhard E; Kao GD; Maity A
    Mol Cancer Res; 2006 Jul; 4(7):471-9. PubMed ID: 16849522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.
    Hudson CC; Liu M; Chiang GG; Otterness DM; Loomis DC; Kaper F; Giaccia AJ; Abraham RT
    Mol Cell Biol; 2002 Oct; 22(20):7004-14. PubMed ID: 12242281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin induces REDD1 expression through hypoxia-inducible factor 1 activation in adipocytes.
    Regazzetti C; Bost F; Le Marchand-Brustel Y; Tanti JF; Giorgetti-Peraldi S
    J Biol Chem; 2010 Feb; 285(8):5157-64. PubMed ID: 19996311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1α pathway.
    Huang W; Ding X; Ye H; Wang J; Shao J; Huang T
    Neuroreport; 2018 Dec; 29(18):1578-1585. PubMed ID: 30371540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1.
    Baumann MU; Zamudio S; Illsley NP
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C477-85. PubMed ID: 17442736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells.
    Hayashi M; Sakata M; Takeda T; Yamamoto T; Okamoto Y; Sawada K; Kimura A; Minekawa R; Tahara M; Tasaka K; Murata Y
    J Endocrinol; 2004 Oct; 183(1):145-54. PubMed ID: 15525582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA; Ashcroft M
    Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.